K. Stegmeier
- Clinical Biochemistry top 5%
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology 4
- Pharmacology top 10%
- Pharmacology and Obesity Treatment 4
- Inflammatory mediators and NSAID effects 4
-
- Antiplatelet Therapy and Cardiovascular Diseases 7
-
- Pharmacology and Obesity Treatment 4
- Inflammatory mediators and NSAID effects 4
-
- Cholesterol and Lipid Metabolism 7
-
- Liver Disease Diagnosis and Treatment 3
-
- Cancer, Lipids, and Metabolism 3
-
- Peroxisome Proliferator-Activated Receptors 3
- Co-authors
- H. PatschekeJ. PillH. Dariush FahimiF. H. SchmidtSadaki YokotaJohannes AufenangerB. Müller‐BeckmannJohannes Pill
- Journals
- Annals of the New York Academy of Sciences (3 papers)Thrombosis Research (2 papers)Hormone and Metabolic Research (2 papers)
- Partner nations
- GermanyUnited StatesIsrael
In The Last Decade
K. Stegmeier
29 papers receiving 543 citations
Peers
Comparison fields: 5 of 73
- Clinical Biochemistry 75
- Biochemistry 78
- Pharmacology 115
- Cardiology and Cardiovascular Medicine 115
- Pharmacology 39
Countries citing papers authored by K. Stegmeier
This map shows the geographic impact of K. Stegmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Stegmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Stegmeier more than expected).
Fields of papers citing papers by K. Stegmeier
This network shows the impact of papers produced by K. Stegmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Stegmeier. The network helps show where K. Stegmeier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside K. Stegmeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 8 | |
| 2 | 1995 | 2 | |
| 3 | 1993 | 6 | |
| 4 | 1992 | 1 | |
| 5 | 1991 | 8 | |
| 6 | Investigations of the antiatherosclerotic effect of the thromboxane A2 receptor antagonist Daltroban. | 1990 | 6 |
| 7 | 1988 | 3 | |
| 8 | Effect of bezafibrate on serum lipids in normo- and spontaneously hyperlipidemic rats. | 1988 | 5 |
| 9 | 1987 | 12 | |
| 10 | 1987 | 13 | |
| 11 | 1986 | 9 | |
| 12 | 1986 | 13 | |
| 13 | 1985 | 7 | |
| 14 | Effects of the prostaglandin H2/thromboxane A2 antagonist BM 13.177 on human platelets. | 1985 | 3 |
| 15 | 1985 | 8 | |
| 16 | Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death. | 1984 | 18 |
| 17 | 1982 | 17 | |
| 18 | 1982 | 112 | |
| 19 | 1981 | 5 | |
| 20 | 1978 | 38 |
About K. Stegmeier
K. Stegmeier is a scholar working on Biochemistry, Pharmacology, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Hematology, having authored 29 papers that have together received 577 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Cholesterol and Lipid Metabolism (7 papers), Pharmacology and Obesity Treatment (4 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Inflammatory mediators and NSAID effects (4 papers), Liver Disease Diagnosis and Treatment (3 papers), Cancer, Lipids, and Metabolism (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). The work is most often cited by research in Clinical Biochemistry (75 citations), Biochemistry (78 citations), Pharmacology (115 citations), Cardiology and Cardiovascular Medicine (115 citations) and Pharmacology (39 citations). K. Stegmeier has collaborated with scholars based in Germany, United States and Israel. Frequent co-authors include H. Patscheke, J. Pill, H. Dariush Fahimi, F. H. Schmidt, Sadaki Yokota, Johannes Aufenanger, B. Müller‐Beckmann, Johannes Pill, G. Neugebauer and Eveline Baumgart‐Vogt. Their work appears in journals such as Annals of the New York Academy of Sciences, Thrombosis Research, Hormone and Metabolic Research, Clinical Pharmacology & Therapeutics and Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.